According to Prelude Therapeutics's latest financial reports the company's current revenue (TTM ) is HK$0.13 Billion. In 2025 the company made a revenue of HK$94.45 Million an increase over the revenue in the year 2024 that were of HK$54.34 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.